Are the novel inflammation biomarkers SIRI and SII associated with mortality risk in patients with chronic heart failure?
SIRI and SII are novel inflammation biomarkers associated with mortality risk in chronic heart failure, with SIRI potentially offering better prognostic discrimination than CRP.
SIRI and SII were significantly associated with mortality risk in patients with CHF. SIRI may provide better prognostic discrimination than C-reactive protein.
Zhu et al. (Thu,) studied this question.